CCN3 (NOV) Is a Negative Regulator of CCN2 (CTGF) and a Novel Endogenous Inhibitor of the Fibrotic Pathway in an in Vitro Model of Renal Disease
- 31 May 2009
- journal article
- Published by Elsevier BV in The American Journal of Pathology
- Vol. 174 (5), 1725-1734
- https://doi.org/10.2353/ajpath.2009.080241
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- CCN3 is a novel endogenous PDGF-regulated inhibitor of glomerular cell proliferationKidney International, 2008
- TNF-α, but not IFN-γ, regulates CCN2 (CTGF), collagen type I, and proliferation in mesangial cells: possible roles in the progression of renal fibrosisAmerican Journal of Physiology-Renal Physiology, 2007
- A novel mechanism for BCR-ABL action: stimulated secretion of CCN3 is involved in growth and differentiation regulationBlood, 2006
- Expression and regulation of CCN genes in murine osteoblastsBone, 2006
- Imatinib Attenuates Diabetic Nephropathy in Apolipoprotein E-Knockout MiceJournal of the American Society of Nephrology, 2005
- Connective Tissue Growth Factor Expressed in Tubular Epithelium Plays a Pivotal Role in Renal FibrogenesisJournal of the American Society of Nephrology, 2005
- Glomerular expression of platelet-derived growth factor (PDGF)-A, -B chain and PDGF receptor-?, -? in human diabetic nephropathyClinical and Experimental Nephrology, 2004
- The Expression of novH in Adrenocortical Cells Is Down-regulated by TGFβ1 through c-Jun in a Smad-independent MannerPublished by Elsevier BV ,2002
- Progression of Renal Disease and Renal HypertrophyAnnual Review of Physiology, 1995
- Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform ExtractionAnalytical Biochemistry, 1987